Zobrazeno 1 - 10
of 10
pro vyhledávání: '"MESH: Radiation-Sensitizing Agents"'
Publikováno v:
Cancer/Radiothérapie
Cancer/Radiothérapie, 2022, 26 (1-2), pp.206-212. ⟨10.1016/j.canrad.2021.09.004⟩
Cancer/Radiothérapie, 2022, 26 (1-2), pp.206-212. ⟨10.1016/j.canrad.2021.09.004⟩
International audience; We present the update of the recommendations of the French society of oncological radiotherapy on radiotherapy of laryngeal cancers. Intensity modulated radiotherapy is the standard of care radiotherapy for the management of l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f072f9af021c2fc02817497d79f37bd4
https://hal.archives-ouvertes.fr/hal-03889481
https://hal.archives-ouvertes.fr/hal-03889481
Publikováno v:
Current Drug Targets
Current Drug Targets, Bentham Science Publishers, 2006, 7 (4), pp.423-42
Current Drug Targets, Bentham Science Publishers, 2006, 7 (4), pp.423-42
International audience; Resveratrol (3,4',5 tri-hydroxystilbene) is a phytoalexin produced in hudge amount in grapevine skin in response to infection by Bothrytis cinerea. This production of resveratrol blocks the proliferation of the pathogen, there
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0dcece0354791b85b4765c0c251ec48
https://doi.org/10.2174/138945006776359331
https://doi.org/10.2174/138945006776359331
Publikováno v:
Cancer Radiothérapie
Cancer Radiothérapie, Elsevier Masson, 2011, 15 (6-7), pp.440-444. ⟨10.1016/j.canrad.2011.05.006⟩
Cancer Radiothérapie, Elsevier Masson, 2011, 15 (6-7), pp.440-444. 〈10.1016/j.canrad.2011.05.006〉
Cancer Radiothérapie, Elsevier Masson, 2011, 15 (6-7), pp.440-444. ⟨10.1016/j.canrad.2011.05.006⟩
Cancer Radiothérapie, Elsevier Masson, 2011, 15 (6-7), pp.440-444. 〈10.1016/j.canrad.2011.05.006〉
International audience; Protracted preoperative radiochemotherapy with a 5-FU-based scheme, or a short course of preoperative radiotherapy without chemotherapy, are the standard neoadjuvant treatments for resectable stage II-III rectal cancer. Local
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::fa711816b7701742d8660cdadb87d94d
https://hal.archives-ouvertes.fr/hal-00719140
https://hal.archives-ouvertes.fr/hal-00719140
Publikováno v:
Laryngoscope
Laryngoscope, Wiley, 2010, 120 (4), pp.690-7. ⟨10.1002/lary.20793⟩
Laryngoscope, Wiley, 2010, 120 (4), pp.690-7. 〈10.1002/lary.20793〉
Laryngoscope, Wiley, 2010, 120 (4), pp.690-7. ⟨10.1002/lary.20793⟩
Laryngoscope, Wiley, 2010, 120 (4), pp.690-7. 〈10.1002/lary.20793〉
International audience; OBJECTIVES/HYPOTHESIS: Clinical studies have documented that cytotoxic chemotherapy is often associated with body weight loss and decreased enjoyment of food. Besides taste, olfaction plays a role in food intake. We assessed w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3e12064eebf729e573c8cadf406d93a5
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-00761454
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-00761454
Autor:
Vauleon, Elodie, Mesbah, Habiba, Gedouin, Daniel, Lecouillard, Isabelle, Louvel, Guillaume, Hamlat, Abderrahmane, Riffaud, Laurent, Carsin, Béatrice, Quillien, Véronique, Audrain, Odile, Lesimple, Thierry
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, 2012, 99 (2), pp.121-6. ⟨10.1684/bdc.2011.1528⟩
Bulletin du Cancer, John Libbey Eurotext, 2012, 99 (2), pp.121-6. ⟨10.1684/bdc.2011.1528⟩
Bulletin du Cancer, 2012, 99 (2), pp.121-6. ⟨10.1684/bdc.2011.1528⟩
Bulletin du Cancer, John Libbey Eurotext, 2012, 99 (2), pp.121-6. ⟨10.1684/bdc.2011.1528⟩
International audience; Despite progress in the initial management of glioblastoma (GB), the vast majority of patients will experience recurrence within 2-3 years. The medical treatment of these recurrences is being modified by the use of antiangioge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b62f758d962f7570da705007e28c72a1
https://www.hal.inserm.fr/inserm-00662493
https://www.hal.inserm.fr/inserm-00662493
Autor:
Emmanuel L. Barbier, Stéphane Bauge, Claire Rome, Didier Clarençon, Jean-Luc Coll, Chantal Rémy, Aurélie Herbette, Nicolas Pannetier, Marie Dutreix, Jian-Sheng Sun, Régine Farion, Leire Azurmendi, Nicolas Coquery, Véronique Josserand
Publikováno v:
PLoS ONE
PLoS ONE, Public Library of Science, 2012, 7 (7), pp.e40567. ⟨10.1371/journal.pone.0040567⟩
PLoS ONE, 2012, 7 (7), pp.e40567. ⟨10.1371/journal.pone.0040567⟩
PLoS ONE, Vol 7, Iss 7, p e40567 (2012)
PLoS ONE, Public Library of Science, 2012, 7 (7), pp.e40567. ⟨10.1371/journal.pone.0040567⟩
PLoS ONE, 2012, 7 (7), pp.e40567. ⟨10.1371/journal.pone.0040567⟩
PLoS ONE, Vol 7, Iss 7, p e40567 (2012)
International audience; BACKGROUND: Glioma is the most aggressive tumor of the brain and the most efficient treatments are based on radiotherapy. However, tumors are often resistant to radiotherapy due to an enhanced DNA repair activity. Short and st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::963f488751cf4793c190655a60a564fc
https://www.hal.inserm.fr/inserm-00874418/document
https://www.hal.inserm.fr/inserm-00874418/document
Autor:
Patrick Merle, Andrei Tchirkov, Bertrand Evrard, Pierre Verrelle, Phong Tran, Emmanuel Chautard, Anne De Cian, Lionel Guittat, Marie-Paule Teulade-Fichou, Jean-Louis Mergny, Jean-Marie Lehn, Anne Petitjean
Publikováno v:
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics, American Association for Cancer Research, 2011, 10 (10), pp.1784-1795. ⟨10.1158/1535-7163.MCT-10-0664⟩
Molecular Cancer Therapeutics, American Association for Cancer Research, 2011, 10 (10), pp.1784-95. ⟨10.1158/1535-7163.MCT-10-0664⟩
Molecular Cancer Therapeutics, 2011, 10 (10), pp.1784-95. ⟨10.1158/1535-7163.MCT-10-0664⟩
Molecular Cancer Therapeutics, American Association for Cancer Research, 2011, 10 (10), pp.1784-1795. ⟨10.1158/1535-7163.MCT-10-0664⟩
Molecular Cancer Therapeutics, American Association for Cancer Research, 2011, 10 (10), pp.1784-95. ⟨10.1158/1535-7163.MCT-10-0664⟩
Molecular Cancer Therapeutics, 2011, 10 (10), pp.1784-95. ⟨10.1158/1535-7163.MCT-10-0664⟩
The aim of this study was to test in vitro the efficacy of TAC, an original G-quadruplex ligand, as a potential radiosensitizing agent for glioblastoma multiforme (GBM). Two human radioresistant telomerase-positive GBM cell lines (SF763 and SF767) we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4e4fad1fb9a76aa9599557a98b8124f
https://hal-mnhn.archives-ouvertes.fr/mnhn-02619098
https://hal-mnhn.archives-ouvertes.fr/mnhn-02619098
Publikováno v:
Bull Cancer
Bull Cancer, 2011, 98 (3), pp.277-90. ⟨10.1684/bdc.2011.1330⟩
Bull Cancer, 2011, 98 (3), pp.277-90. ⟨10.1684/bdc.2011.1330⟩
Poly(ADP-ribosyl)ation is a post-translational modification of proteins catalyzed by poly(ADP-ribose) polymerases (PARPs). In response to genotoxic stress, PARP-1 senses DNA breaks and through the synthesis of poly(ADP-ribose) restores genome integri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8672d8382707bb971cff34c5ac345042
https://hal.archives-ouvertes.fr/hal-02369948
https://hal.archives-ouvertes.fr/hal-02369948
Autor:
Martin E. Gleave, O. Chapet, Emmanuel Watkin, Elie Hadchity, Christian Paulin, Emma Armandy, Claire Rodriguez-Lafrasse, Robert Rousson, Marie-Thérèse Aloy
Publikováno v:
Molecular Therapy
Molecular Therapy, Cell Press, 2009, 17 (8), pp.1387-94. ⟨10.1038/mt.2009.90⟩
Molecular Therapy, Cell Press, 2009, 17 (8), pp.1387-94. ⟨10.1038/mt.2009.90⟩
International audience; In a wide range of human cancers, increased levels of heat shock protein 27 (Hsp27) are closely associated with tumorigenesis, metastasis, resistance to anticancer therapeutics, and thus poor prognosis. In this study, we evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7248475ab59556b3bb501db39c8a0037
https://hal.archives-ouvertes.fr/hal-00466410
https://hal.archives-ouvertes.fr/hal-00466410
Autor:
Martine Mege, Jean-Pierre Benoit, V G Roullin, Erik Gamelin, Laurent Lemaire, Jean-Pierre Cueyssac, Philippe Menei, Marie-Claire Venier-Julienne
Publikováno v:
Pharmaceutical Research
Pharmaceutical Research, American Association of Pharmaceutical Scientists, 2004, 21 (9), pp.1558-1563. ⟨10.1023/b:pham.0000041448.22771.48⟩
ResearcherID
Pharmaceutical Research, American Association of Pharmaceutical Scientists, 2004, 21 (9), pp.1558-1563. ⟨10.1023/b:pham.0000041448.22771.48⟩
ResearcherID
To determine (i) the efficiency of radiosensitizing 5-FU-loaded microspheres and (ii) the impact of microparticle formulation on response to treatment.C6 tumor-bearing rats were stereotactically implanted with microspheres and/or allocated to: contro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e78afc45de51115e2c5634b16242bf14
https://hal.univ-angers.fr/hal-02375468
https://hal.univ-angers.fr/hal-02375468